List of works - Afshin Derakhshani

COVID-19 Infection: Concise Review Based on the Immunological Perspective

scientific article published on 28 September 2020

Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials

scientific article published on 22 June 2020

Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death

scientific article published on 23 April 2020

Evaluation of the frequency of invariant natural killer T (iNKT) cells in nasal polyps

scientific article published on 29 May 2019

Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer

scientific article published on 17 June 2020

Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study

scientific article published on 27 September 2019

Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?

scientific article published on 05 November 2020

Interactions between cancer stem cells, immune system and some environmental components: Friends or foes?

scientific article published on 09 March 2019

Mast cells: A double-edged sword in cancer

scientific article published on 21 March 2019

MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers

scientific article published on 08 April 2020

MicroRNAs and breast cancer stem cells: Potential role in breast cancer therapy

scientific article published on 26 October 2018

Optimization of induction parameters, structure quality assessment by ATR-FTIR and in silico characterization of expressed recombinant polcalcin in three different strains of Escherichia coli

scientific article published on 11 July 2019

Overcoming trastuzumab resistance in HER2-positive breast cancer using combination therapy

scientific article published on 30 September 2019

Small interfering RNA targeting alpha7 nicotinic acetylcholine receptor sensitizes hepatocellular carcinoma cells to sorafenib

scientific article published on 18 January 2020

Targeting TGF-β-Mediated SMAD Signaling Pathway via Novel Recombinant Cytotoxin II: A Potent Protein from Naja naja oxiana Venom in Melanoma